Health

Results: 3757-3768 of 9286

CARB-X Grants Debiopharm an Additional $12.3 Million to Advance Development of Novel Antibiotic Against Gonorrhea

PR Newswire associated0

Phenomenex Unveils New LC Column Connector for Optimized LC and Low-Flow Separations

PR Newswire associated0

Sampled Renews MIA (IMP) License with MHRA Certification

PR Newswire associated0

EpiVax Appoints Dr. Vibha Jawa to Lead Scientific Strategy as CSO

Sobi to share new clinical data and research at EULAR 2025

PR Newswire associated0

Alamar Biosciences joins forces with SciLifeLab to advance understanding of human disease

EpiMonitor is a medical-grade wearable solution for people living with epilepsy. Designed for daily life, it combines night & day, high-accuracy seizure monitoring with comprehensive health tracking. It is the only wrist-worn device and companion app combination fully cleared by the FDA for epilepsy monitoring.

Empatica Achieves CE MDR Certification for EpiMonitor, Bringing Round-the-Clock Epilepsy Monitoring to Europe

Sectra equips multi-site US health system with enterprise imaging as a cloud service and accelerates AI adoption for improved patient diagnostics

PR Newswire associated0

Experimental Drug Development Centre Granted U.S. FDA Fast Track Designation for Antibody-Drug Conjugate EBC-129 to Treat Pancreatic Ductal Adenocarcinoma

Galderma Buys Back Shares Worth CHF 233 Million in the Context of Accelerated Bookbuild Offering

IonOpticks Generation 4 Aurora Series® sets a new benchmark in chromatography

Galderma Intends to Buy Back approximately 2.4 Million Shares in the Context of the Accelerated Bookbuild Offering by EQT, ADIA and Auba